Noch Evan K, Pham Dan, Kitago Tomoko, Wuennemann Marissa, Wortman-Jutt Susan, Falo M Cristina
Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Destroke, Inc., USA.
Heliyon. 2023 Jul 20;9(8):e18393. doi: 10.1016/j.heliyon.2023.e18393. eCollection 2023 Aug.
Stroke is a leading cause of severe disability in the United States, but there is no effective method for patients to accurately detect the signs of stroke at home. We developed a mobile app, Destroke, that allows remote performance of a modified NIH stroke scale (NIHSS) by patients.
To assess the feasibility of a mobile app for stroke monitoring and education by patients with a history of stroke.
We enrolled 25 patients with a history of stroke in a prospective open-label study to evaluate the feasibility of the Destroke app in patients with stroke. Nineteen patients completed all study assessments, with a median time from stroke onset to enrollment of 5.6 years (range 0.1-12 years). We designed a modified NIHSS that assessed 12 out of 16 tasks on the NIHSS. Patients completed this test eight times over a 28-day period. We conducted pre-study surveys that assessed demographic information, stroke and cardiovascular history, baseline NIHSS, and experience using mobile technologies, and mid- and post-study surveys that assessed patient satisfaction on app usage and confidence in stroke detection.
Ten men and nine women participated in this study (median age of 64 (33-76)), representing ten US states and Washington D.C. Median baseline NIHSS was 0 (0-4). 15 patients reported using health apps. On a 5-point Likert scale, patients rated the app as 4.2 on being able to understand and use the app and 4.3 on using the app when instructed by their doctor. For eight patients with poor confidence in detecting the signs of a stroke before the study, six showed higher confidence after the study.
The use of an at-home stroke monitoring app is feasible by patients with a history of stroke and improves confidence in detecting the signs of stroke.
在美国,中风是导致严重残疾的主要原因,但患者在家中尚无准确检测中风迹象的有效方法。我们开发了一款名为Destroke的移动应用程序,它能让患者远程进行改良的美国国立卫生研究院卒中量表(NIHSS)评估。
评估一款移动应用程序用于有中风病史患者进行中风监测和教育的可行性。
我们开展了一项前瞻性开放标签研究,纳入25名有中风病史的患者,以评估Destroke应用程序在中风患者中的可行性。19名患者完成了所有研究评估,从中风发作到入组的中位时间为5.6年(范围0.1 - 12年)。我们设计了一种改良的NIHSS,对NIHSS的16项任务中的12项进行评估。患者在28天内完成了8次该测试。我们进行了研究前调查,评估人口统计学信息、中风和心血管病史、基线NIHSS以及使用移动技术的经验,还进行了研究中和研究后调查,评估患者对应用程序使用的满意度以及对中风检测的信心。
10名男性和9名女性参与了本研究(中位年龄64岁(33 - 76岁)),来自美国10个州和华盛顿特区。基线NIHSS中位数为0(0 - 4)。15名患者报告使用过健康应用程序。在5分制李克特量表上,患者对应用程序在能够理解和使用方面的评分是4.2,在按照医生指示使用方面的评分是4.3。对于8名在研究前对检测中风迹象信心不足的患者,6名在研究后信心增强。
有中风病史的患者使用家庭中风监测应用程序是可行的,并且能提高检测中风迹象的信心。